Literature DB >> 31733824

Aging and influenza vaccine-induced immunity.

Haley L Dugan1, Carole Henry2, Patrick C Wilson3.   

Abstract

Immunosenescence is defined as the progressive deterioration of the immune system with aging. Immunosenescence stifles the generation of protective B and T cell-mediated adaptive immunity in response to various pathogens, resulting in increased disease susceptibility and severity in the elderly population. In particular, immunosenescence has major impacts on the phenotype, function, and receptor repertoire of B and T cells in the elderly, hindering protective responses induced by seasonal influenza virus vaccination. In order to overcome the detrimental impacts of immunosenescence on protective immunity to influenza viruses, we review our current understanding of the effects of aging on adaptive immune responses to influenza and discuss current and future avenues of vaccine research for eliciting more potent anti-influenza immunity in the elderly.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Antibody responses; B cells; Influenza; T cells; Vaccination

Year:  2019        PMID: 31733824     DOI: 10.1016/j.cellimm.2019.103998

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  28 in total

1.  IgD+ age-associated B cells are the progenitors of the main T-independent B cell response to infection that generates protective Ab and can be induced by an inactivated vaccine in the aged.

Authors:  Olivia Kugler-Umana; Wenliang Zhang; Yi Kuang; Jialing Liang; Catherine H Castonguay; Susan L Tonkonogy; Ann Marshak-Rothstein; Priyadharshini Devarajan; Susan L Swain
Journal:  Aging Cell       Date:  2022-09-02       Impact factor: 11.005

Review 2.  Aging and Options to Halt Declining Immunity to Virus Infections.

Authors:  Miguel Ángel Palacios-Pedrero; Albert D M E Osterhaus; Tanja Becker; Husni Elbahesh; Guus F Rimmelzwaan; Giulietta Saletti
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 3.  Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change.

Authors:  Tamas Fulop; Anis Larbi; Graham Pawelec; Alan A Cohen; Guillaume Provost; Abedelouahed Khalil; Guy Lacombe; Serafim Rodrigues; Mathieu Desroches; Katsuiku Hirokawa; Claudio Franceschi; Jacek M Witkowski
Journal:  Vaccines (Basel)       Date:  2022-04-13

Review 4.  Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives.

Authors:  Angelika Wagner; Birgit Weinberger
Journal:  Front Immunol       Date:  2020-04-23       Impact factor: 7.561

5.  Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents.

Authors:  Elliott Bosco; Robertus van Aalst; Kevin W McConeghy; Joe Silva; Patience Moyo; Melissa N Eliot; Ayman Chit; Stefan Gravenstein; Andrew R Zullo
Journal:  JAMA Netw Open       Date:  2021-06-01

6.  Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans.

Authors:  Jiwon Jung; Sophia T Mundle; Irina V Ustyugova; Andrew P Horton; Daniel R Boutz; Svetlana Pougatcheva; Ponraj Prabakaran; Jonathan R McDaniel; Gregory R King; Daechan Park; Maria D Person; Congxi Ye; Bing Tan; Yuri Tanno; Jin Eyun Kim; Nicholas C Curtis; Joshua DiNapoli; Simon Delagrave; Ted M Ross; Gregory C Ippolito; Harry Kleanthous; Jiwon Lee; George Georgiou
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

Review 7.  Circulating Extracellular Vesicles Carry Immune Regulatory miRNAs and Regulate Vaccine Efficacy and Local Inflammatory Response After Vaccination.

Authors:  Hiroyuki Oshiumi
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

Review 8.  The Nature of Immune Responses to Influenza Vaccination in High-Risk Populations.

Authors:  Kristin B Wiggins; Maria A Smith; Stacey Schultz-Cherry
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

Review 9.  The immune response to influenza in older humans: beyond immune senescence.

Authors:  Janet E McElhaney; Chris P Verschoor; Melissa K Andrew; Laura Haynes; George A Kuchel; Graham Pawelec
Journal:  Immun Ageing       Date:  2020-05-07       Impact factor: 6.400

Review 10.  Next-generation direct-acting influenza therapeutics.

Authors:  Mart Toots; Richard K Plemper
Journal:  Transl Res       Date:  2020-02-04       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.